Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In-Depth Characterization of PEGylated Liposomes: Using AF4 and HPLC-CAD in Tandem as a Strategy for Composition Assessment and Postinsertion Optimization.

Analytical chemistry·2026
Same author

Influence of surface characteristics on the in vitro stability and cell uptake of nanoliposomes for brain delivery.

Beilstein journal of nanotechnology·2026
Same author

Functional Properties and Safety Considerations of Zinc Oxide Nanoparticles Under Varying Conditions.

Nanomaterials (Basel, Switzerland)·2025
Same author

Interlaboratory Comparison Reveals State of the Art in Microplastic Detection and Quantification Methods.

Analytical chemistry·2025
Same author

Representative Test Material for Validation of Density Separation as Part of Microplastic Quantification in Drinking Water.

Polymers·2025
Same author

Activity of Azole and Non-Azole Substances Against <i>Aspergillus fumigatus</i> in Clinical and Environmental Samples to Address Antimicrobial Resistance.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Jan 18, 2026

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

13.8K

Challenges in Measuring In Vitro Activity of LNP-mRNA Therapeutics.

Giuditta Guerrini1, Diletta Scaccabarozzi1, Dora Mehn1

  • 1European Commission, Joint Research Centre (JRC), 21027 Ispra, Italy.

International Journal of Molecular Sciences
|September 13, 2025
PubMed
Summary

This study highlights critical quality attributes for lipid nanoparticle-messenger RNA (LNP-mRNA) formulations, focusing on in vitro biological activity for consistent vaccine development. Standardized assays and monitoring are crucial for scalable mRNA therapeutic advancement.

Keywords:
LNP-mRNARNA encapsulationanalytical ultracentrifuge (AUC)drug deliverynanomedicinequalitystabilitytherapeuticsvaccine

More Related Videos

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.8K
Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems
06:18

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems

Published on: April 26, 2019

6.4K

Related Experiment Videos

Last Updated: Jan 18, 2026

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

13.8K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.8K
Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems
06:18

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems

Published on: April 26, 2019

6.4K

Area of Science:

  • Biomedical innovation
  • Drug delivery systems
  • Vaccinology

Background:

  • Messenger RNA (mRNA) therapeutics and vaccines are advancing rapidly.
  • Lipid nanoparticles (LNPs) are a proven delivery platform for mRNA.
  • Ensuring quality and consistency in LNP-mRNA formulations is vital for clinical success.

Purpose of the Study:

  • To explore critical quality attributes of LNP-mRNA formulations.
  • To emphasize the importance of in vitro biological activity for vaccine efficacy and batch consistency.
  • To identify key factors influencing transduction efficiency.

Main Methods:

  • Review of formulation strategies for LNP-mRNA.
  • Analysis of factors affecting in vitro biological activity, including LNP and mRNA components.
  • Examination of cell-line selection, experimental design, storage, and delivery methods.

Main Results:

  • Optimizing LNP components and mRNA structure is essential.
  • In vitro biological activity is a key quality attribute for vaccine performance.
  • Cell-line selection, experimental design, and storage conditions impact transduction efficiency.

Conclusions:

  • Standardized in vitro assays are necessary for reliable LNP-mRNA development.
  • Process-integrated monitoring is crucial for scalable manufacturing and regulatory approval.
  • Further research into optimizing formulation and delivery is warranted for mRNA therapies.